Previous studies have reported that overexpression of CCL2 and its receptors, CCR2, and CCR4, in human cancers, promote lung cancer, breast cancer, and HNSCC development via regulation of angiogenesis, cell proliferation, and migration [5, 7–9, 24, 25]. The gene discussed is CCR2; the disease is head and neck squamous cell carcinoma.